Used in targeted cancer therapies, particularly in folate receptor-mediated drug delivery systems. Its structure allows conjugation to cytotoxic agents, enabling selective uptake by cancer cells overexpressing folate receptors. Commonly employed in the development of antibody-drug conjugates (ADCs) and prodrugs for improved specificity and reduced off-target effects. Also utilized in research settings for studying cellular uptake mechanisms and designing novel antitumor agents.